Regulatory Aspects of Gene Therapy and Cell Therapy Products : A Global Perspective /

Medical literature for health care practitioners on the evaluation and treatment of breastfeeding issues has been disjointed, conflicting, and difficult to find. The field of breastfeeding medicine itself is nonexistent—there are no "breastfeeding doctors" who are specifically trained to u...

Full description

Saved in:
Bibliographic Details
Other Authors: Galli, Maria Cristina (Editor), Serabian, Mercedes (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Series:Advances in experimental medicine and biology ; 871.
Subjects:
Online Access:Connect to this title online

MARC

LEADER 00000nam a22000005i 4500
001 b2837001
005 20240627104325.0
006 m o d
007 cr |||||||||||
008 150915s2015 gw | o |||| 0|eng d
020 |a 9783319186184 
024 7 |a 10.1007/978-3-319-18618-4  |2 doi 
035 |a (DE-He213)spr3555 
040 |d UtOrBLW 
050 4 |a RB155.8 
245 0 0 |a Regulatory Aspects of Gene Therapy and Cell Therapy Products :  |b A Global Perspective /  |c edited by Maria Cristina Galli, Mercedes Serabian. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 871 
505 0 |a 1. Regulatory Oversight of Gene Therapy and Cell Therapy Products in the US - FDA/CBER -- 2. US Oversight of Gene Therapy Products – NIH RAC -- 3. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Canada - Health Canada -- 4. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products -- 5. Regulation of Clinical Trials with Advanced Therapy Medicinal Products (ATMP) in Germany -- 6. EU Clinical Trials Regulatory Oversight of Advanced Therapy Medicinal Products (ATMP): Perspectives from Various Member States -- 7. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Switzerland - Swissmedic -- 8. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Japan - Japan Ministry of Health, Labour and Welfare (MHLW) and Pharmaceutical and Medical Device Agency (PMDA) -- 9. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea - Korean Ministry of Food and Drug Safety (MFDS) -- 10. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Taiwan - Taiwan Food and Drug Administration (TFDA) -- 11. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Singapore - Singapore Health Science Authorities (HSA) -- 12. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Brazil - National Health Surveillance Agency (ANVISA). 
520 |a Medical literature for health care practitioners on the evaluation and treatment of breastfeeding issues has been disjointed, conflicting, and difficult to find. The field of breastfeeding medicine itself is nonexistent—there are no "breastfeeding doctors" who are specifically trained to understand this complex and interactive process. While much of the literature about breastfeeding describes how it "should" work, there is currently nothing available to explain why it often fails and how to treat it. Clinician’s Guide to Breastfeeding: Evidence-based Evaluation and Management is written for health care practitioners who work with breastfeeding mothers; physicians, nurses, nurse practitioners, and lactation consultants. It provides clear information and clinically tested strategies to help professionals guide new mothers to breastfeed successfully. The first of its kind to consider the entirety of the breastfeeding experience, Clinician’s Guide to Breastfeeding is written by Dr. Linda D. Dahl, a leading expert on the subject. It is a comprehensive review of breastfeeding, covering objective analyses of ideal or “normal” nursing, as well as the evaluation and treatment of abnormal nursing, including case studies to illustrate the treatment decision-making process. 
650 0 |a Medicine.  |0 http://id.loc.gov/authorities/subjects/sh85083064 
650 0 |a Gene therapy.  |0 http://id.loc.gov/authorities/subjects/sh85053738 
650 1 4 |a Biomedicine. 
650 2 4 |a Gene Therapy. 
650 7 |a Medicine.  |2 fast  |0 (OCoLC)fst01014893 
650 7 |a Gene therapy.  |2 fast  |0 (OCoLC)fst00939638 
700 1 |a Galli, Maria Cristina,  |e editor.  |0 http://id.loc.gov/authorities/names/n2001145691 
700 1 |a Serabian, Mercedes,  |e editor.  |0 http://id.loc.gov/authorities/names/nb2015021133 
740 0 |a Springer 2015 E-Book Package 
776 0 8 |i Printed edition:  |z 9783319186177 
830 0 |a Advances in experimental medicine and biology ;  |v 871.  |0 http://id.loc.gov/authorities/names/n42001229 
856 4 0 |u https://login.libproxy.scu.edu/login?url=https://dx.doi.org/10.1007/978-3-319-18618-4  |z Connect to this title online  |t 0 
907 |a .b28370016  |b 240629  |c 160414 
918 |a .bckstg  |b 2016-12-01 
919 |a .ulebk  |b 2016-02-22 
998 |a uww  |b 160414  |c m  |d z   |e l  |f eng  |g gw   |h 0 
999 f f |i 11de6673-90ba-5bb7-aab8-660ac890ad63  |s 5d7a3f2e-339e-5069-806d-398d98287d71  |t 0